Evidence map›Paper›PMID 25633388›Full record

ArticleGenome biology2015

DNA methylation age of blood predicts all-cause mortality in later life.

Riccardo E Marioni, Sonia Shah, Allan F McRae, Brian H Chen, Elena Colicino, Sarah E Harris, Jude Gibson, Anjali K Henders, Paul Redmond, Simon R Cox and 21 more

2 registry-linked trialsOpen access · hybridAbstract read
In one paragraph

Article in Genome biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 712 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
712citing papers in PubMed, 9 pooled it
56.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03353597 phase1 / phase2unknown statusnot on this mapstarted 2018, after this paper: background citation

Reversing Epigenetic & Other Markers of Senescence by Transfusing Young Plasma To Older Human Subjects

TypeinterventionalSponsorChandra DuggiralaRan2018 to 2022Enrolled2,120ConditionsAgingArmsPlasma Transfusion
NCT05110313 phase4completednot on this mapstarted 2022, after this paper: background citation

Effects of Tildrakizumab (ILUMYA) Use on Epigenetic Age Acceleration and Psoriasis

TypeinterventionalSponsorCarlos WambierRan2022 to 2024Enrolled30ConditionsPsoriasis, Aging, Epigenetic Disorder, InflammationArmsTILDRAKIZUMAB
3 · Its place in the literature

Who cites it

712 citing papers in PubMed, 9 syntheses or guidelines pooled it, 1,342 citations in OpenAlex.

  1. Accelerated epigenetic age in hypertension: a systematic review and meta-analysis.Hypertension research : official journal of the Japanese Society of Hypertension · 2026
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Trial
  11. Trial
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

652 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 12 institutions in 3 countries.

Riccardo E MarioniCentre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, 7 George Square, Edinburgh, EH8 9JZ, UK. riccardo.marioni@ed.ac.uk.
Sonia ShahQueensland Brain Institute, The University of Queensland, Brisbane, 4072, QLD, Australia. s.shah1@uq.edu.au.
Allan F McRaeQueensland Brain Institute, The University of Queensland, Brisbane, 4072, QLD, Australia. a.mcrae@uq.edu.au.
Brian H ChenThe NHLBI's Framingham Heart Study, Framingham, MA, 01702, USA. brian.chen@nih.gov.
Elena ColicinoDepartment of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA. ecolicin@hsph.harvard.edu.
Sarah E HarrisCentre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, 7 George Square, Edinburgh, EH8 9JZ, UK. Sarah.Harris@igmm.ed.ac.uk.
Jude GibsonWellcome Trust Clinical Research Facility, University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh, EH4 2XU, UK. jgibson6@staffmail.ed.ac.uk.
Anjali K HendersQueensland Institute of Medical Research Berghofer Medical Research Institute, Brisbane, 4029, QLD, Australia. Anjali.Henders@qimrberghofer.edu.au.
Paul RedmondDepartment of Psychology, University of Edinburgh, Edinburgh, EH8 9JZ, UK. paul.redmond@ed.ac.uk.
Simon R CoxCentre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, 7 George Square, Edinburgh, EH8 9JZ, UK. simon.cox@ed.ac.uk.
Alison PattieDepartment of Psychology, University of Edinburgh, Edinburgh, EH8 9JZ, UK. Alison.Pattie@ed.ac.uk.
Janie CorleyDepartment of Psychology, University of Edinburgh, Edinburgh, EH8 9JZ, UK. janie.corley@ed.ac.uk.
Lee MurphyWellcome Trust Clinical Research Facility, University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh, EH4 2XU, UK. Lee.Murphy@ed.ac.uk.
Nicholas G MartinQueensland Institute of Medical Research Berghofer Medical Research Institute, Brisbane, 4029, QLD, Australia. Nick.Martin@qimrberghofer.edu.au.
Grant W MontgomeryQueensland Institute of Medical Research Berghofer Medical Research Institute, Brisbane, 4029, QLD, Australia. Grant.Montgomery@qimrberghofer.edu.au.
Andrew P FeinbergCenter for Epigenetics, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA. afeinberg@jhu.edu.
M Daniele FallinCenter for Epigenetics, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA. dfallin@jhu.edu.
Michael L MulthaupCenter for Epigenetics, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA. mmulthaup@gmail.com.
Andrew E JaffeDepartment of Mental Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, 21205, USA. andrew.jaffe@libd.org.
Roby JoehanesThe NHLBI's Framingham Heart Study, Framingham, MA, 01702, USA. robyjoehanes@hsl.harvard.edu.
Joel SchwartzDepartment of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA. jschwrtz@hsph.harvard.edu.
Allan C JustDepartment of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA. acjust@hsph.harvard.edu.
Kathryn L LunettaThe NHLBI's Framingham Heart Study, Framingham, MA, 01702, USA. klunetta@bu.edu.
Joanne M MurabitoThe NHLBI's Framingham Heart Study, Framingham, MA, 01702, USA. murabito@bu.edu.
John M StarrCentre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, 7 George Square, Edinburgh, EH8 9JZ, UK. jstarr@staffmail.ed.ac.uk.
Steve HorvathHuman Genetics, Gonda Research Center, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, 90095-7088, USA. shorvath@mednet.ucla.edu.
Andrea A BaccarelliDepartment of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA. abaccare@hsph.harvard.edu.
Daniel LevyThe NHLBI's Framingham Heart Study, Framingham, MA, 01702, USA. levyd@nhlbi.nih.gov.
Peter M VisscherCentre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, 7 George Square, Edinburgh, EH8 9JZ, UK. peter.visscher@uq.edu.au.
Naomi R WrayQueensland Brain Institute, The University of Queensland, Brisbane, 4072, QLD, Australia. naomi.wray@uq.edu.au.
Ian J DearyCentre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, 7 George Square, Edinburgh, EH8 9JZ, UK. i.deary@ed.ac.uk.
Framingham Heart Study · USUniversity of Edinburgh · GBHarvard University · USUniversity of Queensland · AUQIMR Berghofer Medical Research Institute · AUJohns Hopkins Medicine · USJohns Hopkins University · USWellcome Trust · GBAlzheimer Scotland · GBMRC Institute of Genetics and Molecular Medicine · GBTranslational Research Institute · AUUniversity of California, Los Angeles · US

Funding

BIOCHEMISTRY, CELLULAR AND MOLECULAR BIOLOGY PROGRAMT32GM007445 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI GREEN, RACHEL · 1985 to 2021
$24.1M
Epigenetic Effects of Particles and Metals on Cardiac Health of an Aging CohortR01ES015172 · NIEHS · HARVARD SCHOOL OF PUBLIC HEALTH · PI SCHWARTZ, JOEL D · 2006 to 2015
$4.8M
The Role and Genetic Mechanism of Epigenetic Plasticity in Age-Related DiseaseR01AG042187 · NIA · JOHNS HOPKINS UNIVERSITY · PI FALLIN, M DANIELE, FEINBERG, ANDREW P. · 2011 to 2015
$4.1M
Environment, Fetal Tissue DNA Methylation & BirthweightR01ES020268 · NIEHS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BACCARELLI, ANDREA, WRIGHT, ROBERT O · 2011 to 2013
$2.5M
Molecular and Epigenetic Mitochondriomics of Air Particles, Lead and CognitionR01ES021733 · NIEHS · HARVARD SCHOOL OF PUBLIC HEALTH · PI BACCARELLI, ANDREA · 2012 to 2015
$2.4M
Exceptional Aging Across the Life Span: Framingham StudyR01AG029451 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI MURABITO, JOANNE M · 2008 to 2011
$1.3M
THE FRAMINGHAM HEART STUDY-N01HC25195-268025195-268025195N01HC025195 · HC · TRUSTEES OF BOSTON UNIVERSITY · PI WOLF, PHILIP A · 2002 to 2006
–
Biotechnology and Biological Sciences Research Council BB/F019394/1Chief Scientist Office CZB/4/505Chief Scientist Office ETM/55Medical Research Council G0700704Medical Research Council MR/K026992/1NHLBI NIH HHS N01 HC025195NIA NIH HHS R01 AG029451NIA NIH HHS R01AG029451NIA NIH HHS R01 AG042187NIEHS NIH HHS R01 ES015172NIEHS NIH HHS R01ES015172NIEHS NIH HHS R01 ES020268NIEHS NIH HHS R01 ES021733NIEHS NIH HHS R01ES021733NIGMS NIH HHS T32 GM007445Wellcome Trust
6 · The paper itself

Abstract

backgroundDNA methylation levels change with age. Recent studies have identified biomarkers of chronological age based on DNA methylation levels. It is not yet known whether DNA methylation age captures aspects of biological age.

resultsHere we test whether differences between people's chronological ages and estimated ages, DNA methylation age, predict all-cause mortality in later life. The difference between DNA methylation age and chronological age (Δage) was calculated in four longitudinal cohorts of older people. Meta-analysis of proportional hazards models from the four cohorts was used to determine the association between Δage and mortality. A 5-year higher Δage is associated with a 21% higher mortality risk, adjusting for age and sex. After further adjustments for childhood IQ, education, social class, hypertension, diabetes, cardiovascular disease, and APOE e4 status, there is a 16% increased mortality risk for those with a 5-year higher Δage. A pedigree-based heritability analysis of Δage was conducted in a separate cohort. The heritability of Δage was 0.43.

conclusionsDNA methylation-derived measures of accelerated aging are heritable traits that predict mortality independently of health status, lifestyle factors, and known genetic factors.

Indexed as

Cause of DeathMortalityAgedAgingBloodCohort StudiesDemographyDNA MethylationFemaleHumansInheritance PatternsLeukocyte CountMaleRisk FactorsSurvival Analysis

Identifiers

PMID25633388
PMCPMC4350614
OpenAlexW2159536887

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.